and €10 million in Lyon Gerland to produce Tzield (teplizumab), a biologic for type 1 diabetes that Sanofi acquired last year from Provention Bio in a $2.9 billion deal. “With these ...

Hospices Civils de Lyon) university hospital platform has been manufacturing the product as a magistral preparation, helping patients with the last remaining stock of active ingredient available from ...

LYON, France--(BUSINESS WIRE)--Osta Therapeutics ... Dr. Gilles Courtemanche brings more than 20 years of experience in drug development from positions at Rhône-Poulenc, Sanofi, and Synthelabo. Most ...

Fouque (CHU, Lyon-Sud) et L. Juillard (CHU Edouard Herriot ... since 2012 and Vifor France since 2018, Sanofi-Genzyme from 2012 to 2015, Baxter and Merck Sharp & Dohme-Chibret (MSD France) from 2012 ...

Sanofi and J&J discontinued E.mbrace phase 3 study after the vaccine showed insufficient efficacy in preventing invasive E. coli disease. Sanofi recorded a $250M impairment charge, lowering Q4 ...

The year 2024 was marked by a gradual shift in central banks’ monetary policy after several months of high rates aimed at ...

Sanofi said this morning that its pipeline includes 12 potential blockbuster drugs that could generate more than €10 billion ($11 billion) in annual sales by the end of the decade, a sharp ...

Patients to pay no more than $35 a month Eli Lilly, Sanofi previously settled overcharging claims Novo Nordisk denies wrongdoing, pledges affordable insulin Jan 27 (Reuters) - Novo Nordisk (NOVOb ...

Hamas proposed releasing all hostages for a lasting truce. It also rejected Israel's call for its disarmament and removal from Gaza. Rebuilding Gaza could cost $53.2 billion, according to ...

He was well-supported by the ever-dependable Nathan Lyon, who spun a web around the Sri Lankan batters to finish with seven match wickets. Sri Lanka's heaviest defeat before Saturday was in Nagpur in ...

The oversubscribed series B financing was co-led by EQT Life Sciences and Sanofi Ventures, according to a Jan. 28 release. Existing investor F-Prime Capital also joined the round, with ...